Type 3c pancreatogenic diabetes is diabetes that arises from structural pancreatic disease — most commonly chronic pancreatitis — and is characterized by deficiency of both insulin and glucagon, brittle glucose control, and coexisting exocrine pancreatic insufficiency. It is often misdiagnosed as type 2 diabetes; research suggests up to 8 percent of adults labeled with type 2 may actually have type 3c.
What Is Type 3c Diabetes?
The American Diabetes Association classifies diabetes into four main categories — type 1, type 2, gestational, and “other specific types” (referred to historically as type 3). Type 3c is the subcategory caused by disease of the exocrine pancreas. Because pancreatic damage affects both the islets and the surrounding exocrine tissue, type 3c has a distinct clinical signature.
Causes
| Cause | Approximate Share of Type 3c Cases |
|---|---|
| Chronic pancreatitis | ~80% |
| Pancreatic surgery (pancreatectomy) | ~5 to 10% |
| Pancreatic cancer | ~5 to 10% |
| Cystic fibrosis | Variable — addressed as CFRD in many centers |
| Hereditary pancreatitis | Rare |
| Hemochromatosis (iron overload) | Rare |
| Other (trauma, autoimmune pancreatitis) | Rare |
Chronic Pancreatitis
Long-standing inflammation and fibrosis of the pancreas destroy both exocrine acinar tissue and endocrine islets. Alcohol is the most common cause of chronic pancreatitis worldwide; other causes include genetic variants (PRSS1, SPINK1, CFTR), recurrent gallstone disease, and autoimmune pancreatitis.
Pancreatic Surgery
Partial or total pancreatectomy — for tumors, severe pancreatitis, or trauma — predictably reduces beta-cell mass. Total pancreatectomy produces “surgical diabetes” with complete insulin and glucagon deficiency.
Pancreatic Cancer
New-onset diabetes in adults older than 50 can be an early sign of pancreatic ductal adenocarcinoma. Roughly 1 percent of adults with new-onset diabetes develop pancreatic cancer within 3 years.
How Type 3c Differs from Type 1 and Type 2 Diabetes
| Feature | Type 1 | Type 3c | Type 2 |
|---|---|---|---|
| Beta-cell function | Severely reduced | Reduced | Preserved early, declines |
| Alpha-cell function | Preserved | Reduced (glucagon deficiency) | Preserved or excess |
| Exocrine pancreas | Normal | Insufficient | Normal |
| Autoantibodies | Positive | Negative | Negative |
| Glycemic control pattern | Variable | Brittle — frequent highs and lows | Generally stable |
| Hypoglycemia recovery | Normal counterregulation | Impaired — glucagon deficient | Normal |
| Treatment of choice | Insulin | Insulin often early; PERT | Lifestyle plus oral agents |
Symptoms
- Frequent fluctuations between hyperglycemia and hypoglycemia (“brittle” diabetes)
- Weight loss despite normal or increased appetite
- Fatty stools (steatorrhea) — pale, oily, foul-smelling
- Abdominal pain (especially in chronic pancreatitis)
- Bloating and flatulence after fatty meals
- Fat-soluble vitamin deficiencies — vitamin A, D, E, K
- Reduced bone density (vitamin D deficiency)
Diagnosis
Suspecting Type 3c
Diagnostic suspicion is raised by:
- Imaging or history of pancreatic disease
- Symptoms of exocrine insufficiency (steatorrhea, weight loss)
- Brittle glycemic control with frequent hypoglycemia
- Negative islet autoantibodies
- Low BMI despite diabetes
Confirmatory Testing
- Pancreatic imaging — CT or MRI showing atrophy, calcifications, or ductal abnormality
- Fecal elastase-1 — low levels (under 200 mcg/g) confirm exocrine insufficiency
- Fat-soluble vitamin levels (A, D, E)
- Stool fat measurement (rarely used today)
- C-peptide — typically low but variable
- Autoantibody testing (GAD-65, IA-2) — negative
Treatment
Treatment requires coordination between an endocrinologist and a gastroenterologist or pancreas specialist.
Glucose Management
- Insulin is often required earlier than in typical type 2 diabetes
- Metformin may be appropriate if residual beta-cell function is present and weight loss is not an issue — has some protective association in pancreatic cancer settings
- Sulfonylureas — used with caution due to hypoglycemia risk (no glucagon counter-regulation)
- GLP-1 receptor agonists — caution, theoretical pancreatitis concern in this population
- Continuous glucose monitoring (CGM) is particularly valuable due to brittle control
Pancreatic Enzyme Replacement (PERT)
- Enzymes taken with every meal and snack
- Doses titrated to symptoms and stool elastase
- Improves fat absorption, weight, and vitamin levels
Nutrition
- Adequate calories and protein — patients often need more, not less, food
- Fat-soluble vitamin supplementation (A, D, E, K)
- Calcium and vitamin D for bone health
- Avoid alcohol if chronic pancreatitis is the cause
- Small frequent meals can improve tolerance
For broader nutritional principles, see our diet and nutrition guide.
Managing the Underlying Cause
- Alcohol cessation in pancreatitis
- Pain management — multidisciplinary approach
- Endoscopic or surgical treatment of ductal disease
- Iron removal in hemochromatosis
- Cancer-directed therapy where appropriate
Complications
- Severe hypoglycemia from glucagon deficiency
- Malnutrition and weight loss
- Osteoporosis from vitamin D and calcium malabsorption
- Standard diabetes complications — retinopathy, nephropathy, neuropathy
- Pancreatic cancer risk in chronic pancreatitis
See our overview of complications and related conditions for more on diabetes-related complications.
Prevention
Type 3c is prevented by preventing or treating the underlying pancreatic disease:
- Limit or avoid alcohol — the leading cause of chronic pancreatitis
- Manage gallstone disease promptly to prevent recurrent biliary pancreatitis
- Smoking cessation — independent risk factor for pancreatitis
- Genetic counseling and screening in families with hereditary pancreatitis
- Iron management in hemochromatosis
- Early evaluation of new diabetes in adults over 50, especially with weight loss or abdominal symptoms
Related Reading
For more on atypical diabetes subtypes, see our companion guides on cystic fibrosis-related diabetes, secondary diabetes, LADA, and the prediabetes basics hub.
The Bottom Line
Type 3c pancreatogenic diabetes is diabetes from pancreatic disease — usually chronic pancreatitis — and is distinguished by dual insulin and glucagon deficiency, exocrine pancreatic insufficiency, and brittle glucose control. It is often misdiagnosed as type 2 diabetes; consider it in lean patients with unexplained weight loss, fatty stools, or known pancreatic disease. Treatment combines insulin, pancreatic enzyme replacement, fat-soluble vitamin supplementation, and management of the underlying pancreatic condition. Coordinated care with a gastroenterologist and endocrinologist offers the best outcomes.
